Nobivac KC, ninatilgad, suspensiooni lüofilisaat ja lahusti, koertele
Nobivac KC, ninatilgad, suspensiooni lüofilisaat ja lahusti, koertele
Authorised
- Bordetella bronchiseptica, strain B-C2, Live
- Canine parainfluenza virus, strain Cornell, Live
Product identification
Medicine name:
Nobivac KC, ninatilgad, suspensiooni lüofilisaat ja lahusti, koertele
Active substance:
- Bordetella bronchiseptica, strain B-C2, Live
- Canine parainfluenza virus, strain Cornell, Live
Target species:
-
Dog
Route of administration:
-
Nasal use
Product details
Active substance and strength:
-
Bordetella bronchiseptica, strain B-C2, Live5011870000.00/Colony forming unit1.00dose
-
Canine parainfluenza virus, strain Cornell, Live630957.00/tissue culture infective dose 501.00dose
Pharmaceutical form:
-
Nasal drops, lyophilisate and solvent for suspension
Withdrawal period by route of administration:
-
Nasal use
- Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI07AF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Estonia
Package description:
- Available only in Estonian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- State Agency Of Medicines
Authorisation number:
- 1206
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 26/04/2023
How useful was this page?:
